MNOW — Mednow Income Statement
0.000.00%
Last trade - 00:00
Consumer DefensivesSpeculativeMicro Cap
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.414 | 16.6 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 2.78 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.007 | 0.012 | 0.469 | 9.41 | 46.1 |
Operating Profit | -0.007 | -0.012 | -0.469 | -9 | -29.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.007 | -0.012 | -0.469 | -8.95 | -30.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.007 | -0.012 | -0.469 | -8.95 | -29.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.007 | -0.012 | -0.469 | -8.95 | -29.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.007 | -0.012 | -0.469 | -8.95 | -29.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0.001 | -0.021 | -0.487 | -1.14 |
Dividends per Share |